FT  |  Companies

Eli Lilly and Merck’s blockbuster drug sales power earnings

艾利离和默克的重磅药物销售推动收益

Eli Lilly and Merck’s blockbuster drug sales power earnings
2025-10-30  462词  简单
字体大小
Similarly, Merck raised its full-year earnings guidance range after net income in its latest quarter was boosted by record sales of its top-selling cancer drug.

请登录后继续阅读完整文章

还没有账号？立即注册

成为会员后您将享受无限制的阅读体验，并可使用更多功能，了解更多

免责声明：本文来自网络公开资料，仅供学习交流，其观点和倾向不代表本站立场。